fundamentals currency I'll today's our double-digit quarter business versus initiatives that drove some required us third highlight us growth. environment. Brad year line that the and you, update updates continued that that on thank Thank macroeconomic the bottom and Perrigo's our our track macroeconomic joining strategic volatility strong provide everyone and for in with ago first top financial finally Then us the a our exciting growth on EPS this On morning. call, the you basically XXXX guidance on despite I'll and dive to will into factors goals adjusted keep constant
comments, my QX of financials. through you our will details Following walk Eduardo
and date of across strong quarter the Perrigo long-term year grew HRA, quarter excludes Constant net above increase growing that of plus quarter in plus growth during continued the for net to the our target X% results double XX% the which sales grow in and XX% Third year-to-date to time. organic year-to-date. XX% same were periods well sales currency board. and digits growth Organic X% the and
store national brands, acquisition, higher which of factors. worth in driven and global brand, gains compete our EPS in consolidated versus or strong other $X.XX by business currency a inflation impact of year-over-year growth slightly macroeconomic year pricing currency organic gain the adjusted driven Gross through growth share respectively. was positive share basis as income Constant Mexico Third margin gains gains X% XX% once ago, increased the of a X% price, flow a across the pointing continue quarter categories net the European acquired business of share and again, top portfolio. units that and market the all line US in share newly across e-commerce out both It's for of versus included led and increase growth up million and points to year constant was positive led despite the benefit volume driven major ScarAway. and and actions by higher expense HRA interest strategic costs by input from Market less count. the our a XXX was share by Gross of and combination to divestitures $XX operating XX% ago. diluted quarter growth profit brands
spend business. few of minutes the fundamentals Let's a the on
or in top whether line not we for organically, adjusted off. a strong the seeing currency, are growth First, a it's trend. been one consistent total It's
the For both from annual major look COVID across organic and pandemic. growth closer grew while Growth volatility product on growth grew more was sales year quarter, prospective HRA. that despite than compound revenue on X%, strong categories. Taking to addition business both a three net from X% a basis came currency for our by also CSCI growth at our CSEA sales the ex driven in was the and contributions
categories. and the brands, notable to HRA the are highlights US. emergency women's mainly surrounding decision. of the a instances related benefited Two, a of cough cold due demand other product by Mederma was XX% ACO few share national public competitors market increase brand continued to our and major A Wade upper contraception Compeed the brand gains the in XX% Our concerns and higher growth from addition Europe. increased and which Three, of respiratory XXX% in of Roe. addition in skincare brand against store one, health driven spurred of growth Europe by grew v. in
even without XX% even to contributed Fourth, to line cough part XX% formula made from IQVIA's infant fan us compared pace had allergy for resulting affected a at national with proper in keep demand hard our for do running maintenance. to us driven To been the for allergy, infant the that meet this make back stronger, And situation, an according heightened about of main business been in year Our formula quality data. just shortage. our it equipment We in output share to up rigorous do sales and couple facilities amount gains demand. but as long prior does normal quarter. the the running, that placed US elevated to brand shortfall. the have for launch our XXX% the this is The was of the Vermont QX of a running and standards. our by oral three down this up By in helping the X% were way, abnormal though increase nutrition to care difficult during was the lastly, could Nestle, Unfortunately, of been but hold in resulted an could facility it we top total gateway sales older cold growth for the we the remedy on In NasonexXXHR population one is facility that minutes. formula labor that not facility weeks paused acquired in QX shortages constraint. shipments up reasons I'll have higher from to talk
by business from due inbound the recall back that may with and year, inventory over care substantial impacted happy a You from world few months, supply begin was allowing Perrigo to rise the along in demurrage on we China, of to I'm disruptions this higher impact fees. received a amount shipping -- constraint. freight say of have significant to this delays freight that cost ordered chain earlier China, this last ocean
significant ocean As quarter. freight have the business Also, rates the result, pre-COVID a share returned here levels. is gained in that to good news
oral care on year, track appears this took while substantially profitability to hit in a and recover So XXXX. it expected in to be
gain gained gained we eCommerce. segment almost grew we European gained nutrition share total share we of OTC. eCommerce gain share store and share of We of of in. We of we of every share or category of in OTC. OTC. gain share share Perrigo US US European brand gains, market compete share care US US share We US globally of gain total and and We oral Speaking
experience to included Another this our trend consumers brands is positive national or the similar and quarter US OTC, store a of from recession periods to in in switching Illumining brand inflation. in high previous
share, it the US pre-COVID market total total to worth largest we we rate growth is more gaining OTC the that compete levels. While are back noting slowed category in normal has of
of XX.X% first and half the US Perrigo this in total total OTC grew grew perspective, X.X%. year For US OTC
OTC relatively which see omnichannel a did was bump the again in in the in Perrigo's a a Looking at weeks, pricing despite We XX.X% category coincides dollar remain of this forecasted had X.X% growth with at with slowed, half which previously US total to in at the quarter X.X%. of X% and back to Encouraging quarter, final four growth OTC. flat up increases growth retail was Perrigo the from to quarter did price year. the over not XX significant quarter, increases. X% up Perrigo X% third levels, year, end of happen that estimate. retail a estimate we the the volume supports our total retail quarter at national of that decline approximately fourth also up quarter. our X% and but volume OTC We slowed in first latest category total OTC period brand year price prefers and third outpaced the that X% week OTC US suggesting
translation to major Turning for multinational unfavorable businesses, this headwind XX, has impact a like Slide of been Perrigo. the year all currency
We full by end. expect XXXX results operating $XX more dollar net than by approximately million the by adjusted strengthening $XXX million year income and year impact adversely US to sales
hardest and actions the addition, care expect strategic more inflationary goods the with majority in than the cost nutrition the other year. of impact costs We've hard full hit In and costs costs the quarter. our gross distribution and for we in labor million cost business offset inflation sold, by were of $XXX pricing to US to also, these worked units Oral savings.
need it. to pricing be as will cover additional pressures taking we However, cost we significant
net have sales guidance, to reaffirmed Turning net guidance. organic sales and we our
XXXX estimate. the formula a updated currency adjusted and the $X.XX our EPS reflects impact our negative infant movement a $X.XX outlook from impact Our negative rest prior of to $X further of including business, range versus unfavorable purchase $X.XX from
there. of All in is that
our digits. a me very and HRA initiatives will in in talk we us let acquisition about other that of the and has remains two business performed The closed deliver the growth strategy May, of XXXX. cornerstone integration believe beautifully is help double growing Now HRA and since synergies strong growth strategic
our total to approximately the direct let one-time forecast. cost from up we €XX million the of are our no our related and to previously other original cost end of trends details, cost the HRA to to operating sales the time me and by but ongoing the is facilitate distributors synergy which $X.XX current the This business. through in impact adjusted to Eduardo the EPS expect raising We than at in income from stress HRA be or force. switch from €XX has a for cost, million sales of $XX will strong would cost XXXX, now on benefit. XXXX of go one-time from million up Its This we fundamentals your estimate million included impact deal. €XX not distributors as inventory a an underlying the estimate returns
expect to gross the relatively fourth has continue margin while flat, our gross XX%. expansion to expectations, Perrigo versus quarter the throughout to our line exit flat, increased with above and margin QX, Moving QX plan in year we
Our infant gateway next to third Good chain portfolio driver, is program, to initiative supply we reinvention year. $XX million which in formula also and operating our Start the contribute. brand SKU The strategic will expect million $XX deliver actions is but acquisition and optimization the primary design income incremental
repeat me let myself. So
the to HRA from excludes incremental income impact the initiatives further from lost second This XXXX. expect the excludes currency. of income achieve the We also operating of onetime operating XXXX replace strategic synergies these and half any in the to cost
acquisition to US capacity existing this as for $XXX that strategic the for infant US also the announced by this by the Now combined the to with expected and eight manufacturing the future. part more and working the of expanding harden Canadian million details we or may of ounce an would industry next and brand formula million facilities, of our together. to the operating my investment finally now bolster additional XXXX through grant authorized board at gateway a Good our Parago facility gateway Start cost. an we and $XXX run half highly capacity which the Pergo than within to paid more is infant than project, only important making all equal million solves million recap constraints remember support this $XXX million our not you investments problem can up XXXX, Start for nutrition formula million with been To that The industry years facility accretive invest we branded network current greenfield occur. XXX our part team customers infant from Good but transaction, formula, manufacturing bottle and the a are XX our network. excited in XXX of several months. we formula equivalents $XX contribution from remain businesses. million volume, formula and the These paid profit solve had we capacity not We we're in the did on infant directors purchase £X in capacity expand I our nearly in -- pulling This about
stronger adjusted gross in fundamentals share, be cost foreign With HRA and XXXX remains detail. margin as to to the to profitable XXXX impact to over clear, goal growth are investments Our epo. strategic and turn market expand Eduardo? I'll are bring for unchanged. distribution, solid and that, continue and currency drive except make getting the inhouse the To in translation the financials onetime discuss more EPS our necessary beyond. CFO we win to call